J&J Back In Talks With Actelion, Teva Settles Corruption Probe

Several tuck-in deals and licensing agreements were announced this week while healthcare giant Johnson & Johnson is back in exclusive talks with Actelion regarding a possible deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.